iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,958 shares of the financial services provider’s stock after purchasing an additional 92 shares during the quarter. Transcend Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,449,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of IBB. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth $29,000. Highline Wealth Partners LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter valued at about $30,000. HHM Wealth Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $36,000. Finally, Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $138.91 on Friday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The stock has a 50-day moving average price of $135.61 and a 200 day moving average price of $140.77.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.